Kelly Deck - 11 Jan 2022 Form 4 Insider Report for Inhibrx, Inc.

Role
Chief Financial Officer
Signature
/s/ Kelly D. Deck, attorney-in-fact
Issuer symbol
N/A
Transactions as of
11 Jan 2022
Net transactions value
$0
Form type
4
Filing time
25 Jan 2022, 15:50:03 UTC
Next filing
03 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBX Stock Option (right to buy) Award $0 +20,000 $0.000000 20,000 11 Jan 2022 Common Stock 20,000 $34.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 (1) Twenty-five percent (25%) of the total shares subject to the stock option become exercisable on January 11, 2023, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.